Oppenheimer Equities Analysts Raise Earnings Estimates for Aptose Biosciences Inc. (NASDAQ:APTO)
Aptose Biosciences Inc. (NASDAQ:APTO – Get Rating) (TSE:APS) – Investment analysts at Oppenheimer upped their FY2025 EPS estimates for Aptose Biosciences in a note issued to investors on Tuesday, August 2nd. Oppenheimer analyst M. Biegler now expects that the biotechnology company will earn $0.33 per share for the year, up from their prior forecast of […]